The dental infections in patients undergoing preoperative dental examination before surgical treatment of saccular intracranial aneurysm by Pyysalo, Mika et al.
Pyysalo et al. BMC Res Notes  (2018) 11:600  
https://doi.org/10.1186/s13104-018-3704-z
RESEARCH NOTE
The dental infections in patients 
undergoing preoperative dental examination 
before surgical treatment of saccular intracranial 
aneurysm
Mikko J. Pyysalo1,2* , Liisa M. Pyysalo3, Jenni Hiltunen4, Jorma Järnstedt5, Mika Helminen6,7, 
Pekka J. Karhunen4,8 and Tanja Pessi4,6,7
Abstract 
Objective: Dental bacterial DNA and bacterial-driven inflammation markers have previously been detected in intrac-
ranial aneurysm tissue samples. This study aimed (i) to assess the possible presence of dental infectious foci, (ii) and 
the possible association between typical odontogenic bacteria and clinical dental findings in patients undergoing 
pre-operative dental examination before surgical treatment of saccular intracranial aneurysm. Ninety patients with an 
intracranial aneurysm were recruited to the study, and the patients’ teeth were routinely investigated. Clinical data and 
bacterial samples from the gingival pockets were collected from a subpopulation of 60 patients. Five typical dental 
pathogens and total bacteria amounts were measured from gingival samples using real-time quantitative PCR.
Results: The amounts of total bacterial and Fusobacterium nucleatum DNA were significantly higher in the patients 
with ≥ 6 mm gingival pockets than patients without them (p < 0.01 and p < 0.01, respectively). A total of 43% of
patients with an aneurysm had gingival pockets of 6 mm or deeper. Dental infectious foci are fairly common in the 
Finnish population, with the prevalence of severe periodontitis being around 20%. The frequency of chronic dental 
infections, especially periodontitis seems to be higher in patients with intracranial aneurysm.
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Introduction
The most common chronic oral bacterial disease is peri-
odontitis, and the incidence of severe periodontitis is 
approximately 20% in the Finnish population [1]. Infec-
tion in the gingival pocket leads to pocket deepening, 
thus the depth of gingival pockets is used as an indica-
tor of the severity of periodontal disease [2]. Gingival 
pockets deeper than 6 mm are considered a sign of severe 
periodontitis. Another common dental infection type is 
endodontic infection, which eventually leads to a radio-
logically visible periapical lesion. Chronic periodontitis 
increases the amount of the systemic inflammatory 
mediators C-reactive protein (CRP) and interleukin-6 
(IL-6), as well as total cholesterol and low-density lipo-
protein (LDL) cholesterol levels [3]. Oral infections are 
suggested to play an important role in the pathogenesis 
of cardiovascular diseases, including cerebrovascular dis-
eases, although the direct causality has not been shown 
reliably [4–7].
Periodontal pathogens such as Treponema denticola 
and Porphyromonas gingivalis have been identified in the 
cerebrospinal fluid (CSF) and neuronal ganglia [8, 9]. It 
has been shown that Porphyromonas gingivalis has the 
ability to invade brain tissue through the blood–brain 
barrier leading to neuronal injury via complement C3 
activation [8]. Periodontal pathogens have been suggested 
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to be involved in the rupturing process of intracranial 
aneurysms. In our previous study, we detected bacterial 
DNA of oral origin in 58% of the intracranial aneurysm 
tissue samples and observed highly intensive staining 
of the inflammatory/bacterial receptors CD14 and toll-
like receptor-2 in ruptured aneurysms [10, 11]. The link 
between dental infections and cerebral diseases has also 
been suggested by others [12–14], but to the best of our 
knowledge, there are no other studies assessing the asso-
ciation between the dental infectious burden and the 
gingival bacterial profiles of patients with subarachnoid 
haemorrhage.
The aim of this study was to assess the presence of 
dental infectious foci and to investigate the association 
between typical periodontal/endodontic pathogens and 
clinical dental parameters in patients undergoing preop-




Ninety patients undergoing preoperative dental exami-
nation due to planned surgical treatment of an intrac-
ranial aneurysm were recruited to the study between 
September 2012 and December 2014. Of the patients, 
30 presented with a ruptured aneurysm and 60 with an 
unruptured aneurysm. The inclusion criteria were having 
a saccular aneurysm, being aged between 18 and 99 years, 
having the ability to give informed written consent, and 
having a clinical condition allowing safe transportation to 
the radiological department in the same building.
The patients’ teeth were investigated during the acute 
hospitalization period of aneurysm treatment by an 
experienced oral and maxillofacial surgeon (MP) and 
a study nurse. A routine clinical oral investigation was 
performed. Both panoramic tomography (Scanora 3Dx, 
Tuusula, Finland; 73  kV, 10  mA, 15  s) and dental cone 
beam tomography (Scanora 3Dx, Tuusula, Finland; 
90 kV, 10 mA, 2.4 s, voxel size 0.2 mm) were performed 
for all the patients. Smoking habits were recorded. Peri-
odontal probing was carried out using a standard WHO 
periodontal probe (LM 8-550B Si, LM-instruments Ltd, 
Parainen, Finland) with about 20 g force. Gingival pock-
ets were measured from 6 sites of each tooth and teeth, 
which had one or more (out of the six sites measured) 
≥ 4 mm gingival pocket, were recorded as infection foci. 
Radiological images were examined by an experienced 
dental radiologist (JJ). The presence of furcation lesions, 
vertical pockets and dentine carious lesions were assessed 
from the panoramic tomography. Horizontal bone loss 
was measured as millimeters from the cementoenamel 
junction and considered positive if it was > 2  mm. The 
amount and location of periapical lesions were assessed 
using the dental cone beam tomography.
Samples for bacterial DNA analyses were taken from 
the deepest gingival pocket crevicular fluid of the sub-
population of the 60 patients with an unruptured aneu-
rysm using a sterile blotting paper pin (Pearl Dent Co, Ho 
Chi Minh City, Vietnam).
For the quantitative real-time PCR, the samples were 
equalized according to the measurement of NanoDrop 
(NanoDrop Products Ltd, Wilmington, USA). The DNA 
from five selected typical periodontal and endodontic 
bacteria (Streptococcus sp. mainly Str. mitis group bac-
teria, Prevotella intermedia, Fusobacterium nucleatum, 
Aggregatibacter actinomycetemcomitans, Porphyromonas 
gingivalis) and the total amount of bacterial DNA (univer-
sal bacterial measurement) were measured as previously 
described [15] by real-time quantitative PCR (RT-qPCR) 
using the AbiPrism 7900 HT Sequence Detection Sys-
tem (Applied Biosystems Ltd, California, USA). Shortly, 
for each real-time PCR, 20  μl of a mixture containing 
1 μl of DNA extract, 1× TaqMan Universal Environmen-
tal PCR Master Mix (Applied Biosystems, Foster City, 
Calif., USA), 900 nM (each) sense and antisense primer, 
and 200 nM TaqMan probe were placed in each well of 
a 384-well plate. Amplification and detection were per-
formed using the ABI PRISM 7900 sequence detection 
system (Applied Biosystems). PCR was performed twice 
as duplicates of each sample. In uncertain cases, analy-
ses were repeated. Negative and positive controls were 
included with each batch of samples being analysed. 
The positive control comprised a standard PCR reaction 
mixture containing 5 ng of each reference bacteria listed 
below and the negative control contained sterile water 
instead of the sample. Reference bacteria from the ATCC 
collection (Streptococcus mitis ATCC 49456, Prevotella 
intermedia ATCC 25611, Fusobacterium nucleatum 
subsp. nucleatum ATCC 25586, Aggregatibacter actino-
mycetemcomitans ATCC 700685, Porphyromonas gingi-
valis ATCC 33277, E. coli strain ATCC 25922) were used 
to determine standard curves. From the standard curves, 
the absolute amount of bacterial DNA was calculated 
using the formula: Ct = − slope * log(x) + constant. The 
cut-off values, i.e. detection limits, were 40 cycles for 
all candidate bacteria, except for the Streptococcus sp. 
(mainly the Str. mitis) group (37 cycles) and the universal 
bacterial measurement (34 cycles).
Fisher’s exact test were used to compare the preva-
lences of periapical lesions and gingival pockets ≥ 6 mm 
between smokers and non-smokers.
The absolute amounts of measured bacterial DNA were 
skewed, thus logarithmic values were used in the Mann–
Whitney test to assess the differences in the amounts of 
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bacterial DNA in the samples between the patients with 
and without ≥ 6 mm gingival pockets.
Statistical analyses described above were performed 
with R software [R Core Team (2013). R: A language and 
environment for statistical computing. R Foundation 
for Statistical Computing, Vienna, Austria. URL: http://
www.R-proje ct.org/].
Results and discussion
All the clinical results are presented in Table  1. Of the 
89 aneurysm patients, 56 were females and 33 were 
males. The mean age of the study group was 52.6  years 
(median = 55.5, SD = 10.6). None of the patients had 
diabetes.
Our study shows that altogether 75% of the patients had 
one or more 4–5 mm-deep gingival pocket. The number 
of pockets ranged from 0 to 15 (out of positive findings: 
median = 3, mean = 3.22). Gingival pockets ≥ 6 mm were 
seen in 43% of the patients. The number of such pockets 
ranged from 0 to 14 (out of positive findings: median = 2, 
mean = 3.00). Dental infectious foci are not uncom-
mon in the Finnish population. In Finnish population 
based “Health 2000” study, the prevalence of deep gingi-
val pockets (6 mm or deeper) was reported to be much 
lower, i.e. 21% [1]. Periapical lesions were detected using 
radiographs, as described in materials and methods, in 
38% of the patients, the amount ranging from 0 to 6 (out 
of positive findings: median = 1, mean = 1.68). In gen-
eral population [1], the amount of periapical lesions were 
similar. However, 53% of male patients with an aneu-
rysm had periapical lesions whereas in population based 
study the frequency of the lesions in males was 31%. Our 
results were not biased by smoking (data not shown).
In terms of clinical examination methodology, the 
results between this study and population based Health 
2000 study can be considered comparable. We used simi-
lar WHO standard periodontal probe with a standard 
20 g force (LM 8-550B Si, LM-instruments Ltd, Parainen, 
Finland) that in the control survey. In Health 2000 sur-
vey the clinical examinations were performed in a den-
tal appointment room. In our study, the examination was 
performed in a neurosurgical ward or in an operation 
theatre, depending on a clinical condition of the patient. 
We used additional light (BFV Vistaview II, Louisville, 
Kentucky, USA) and 2.8×–3.2× magnifying loupes 
(Custom made by Surgical Acuity, Wisconsin, Middle-
ton, USA) in every clinical examination to mimic dental 
appointment room conditions. In this study both dental 
cone beam tomography and panoramic tomography were 
performed for all the patients whereas in Health 2000 
study only panoramic tomography was used. Dental cone 
beam tomography is considered more accurate imaging 
modality than panoramic tomography especially in upper 
molar palatal root area. Thus there may be certain bias 
in assessed periapical lesions in upper molar area when 
comparing these two studies.
Amount of gingival bacterial DNA from the sub-cohort 
of 60 patients with an unruptured aneurysm showed that 
the total amounts of bacterial and Fusobacterium nuclea-
tum DNA were significantly higher in the patients with 
≥ 6  mm gingival pockets than patients without them 
(Mann–Whitney-test; p < 0.01 and p < 0.01, respectively; 
Fig.  1). No significant differences were observed among 
the other bacterial DNA measured. Fusobacterium nucle-
atum is a common periodontal pathogen that plays a 
key role in pathogenic subgingival biofilm formation by 
bridging together the early colonizers, like streptococci 
and actinomyces, and the late colonizers [16]. Subgingi-
val biofilm within active periodontal lesions may further 
initiate destructive periodontitis even until bone loss 
[17]. Adhesion molecules of F. nucleatum [18], as well as 
the invasive properties of F. nucleatum [19], may allow 
bacteria to enter the bloodstream, migrate, and cause 
infections elsewhere in the body [20]. In our previous 
study, an increased amount of bacterial DNA and the 
Table 1 Patient characteristics and  the  results of  clinical 
and  radiological assessments of  infection parameters 
of the aneurysm patients
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presence of the same periodontal bacterial species, i.e. 
Fusobacterium nucleatum, along with streptococci was 
also detected in the aneurysm tissue samples [11], sug-
gesting that fusobacteria may escape from oral infection 
foci and be involved in tissue inflammation within the 
cerebral wall.
Conclusions
There are many studies on the general prevalence of peri-
odontitis summarized by Kassebaum et al. [21], and there 
are a few studies concerning the possible association 
between chronic dental infection and stroke [22, 23], but 
to the best of our knowledge, there are no other studies 
on the association between these infections and suba-
rachnoid haemorrhage. In the present study, we showed 
that deep periodontal inflammatory pockets and periapi-
cal lesions were more common in patients with a cerebral 
aneurysm than in the normal population. The results are 
not biased by smoking or diabetes. In addition, gingival 
pocket samples from aneurysm patients with periodon-
titis contained more bacterial DNA and Fusobacterium 
nucleatum DNA than non-inflamed gingivae: the same 
bacteria and increased bacterial amount were previously 
detected to be the most common finding in ruptured and 
non-ruptured cerebral aneurysm samples. Although the 
data in this study is cross-sectional and thus does not 
directly support a cause-effect relationship, these find-
ings together suggest that there may be an association 
between chronic dental infections, especially periodonti-
tis, and saccular intracranial aneurysms. However, these 
results need verification in a larger cohort.
Limitations
We were not able to collect the gingival samples from 
the controls to perform case–control study. However, 
the prevalence of dental infections as well as amount of 
the typical odontogenic taxa in gingival pockets are well 
reported in many studies. Instead collecting own controls 
we used data from population-based study, the “Health 
2000”. The survey consists of 6335 clinically examined 
patients and 6114 panoramic tomographies, represent-
ing well the normal Finnish population. The sample size 
of this study was limited, thus not allowing us to divide 
the patients into reliable representative subgroups. The 
patients in this study are mostly different from our ear-
lier studies [10, 11]. We were not able to determine in this 
study if high fusobacteria levels in gingival pockets corre-
late with bacterial findings per se in the aneurysm. More-
over, there is no consensus on which oral bacterial taxa 
are the most significant in the oral cavity and relevant to 
measure in the gingival pockets of patients with intrac-
ranial aneurysms. Five candidates and the total bacterial 
measurement were selected here, since the selected oral 
bacterial taxa are those most frequently associated in 
infection foci within both the oral cavity and the vascular 
wall [10, 11, 24–27].
Additional files
Additional file 1. Demographic and clinical findings of all patients.
Additional file 2. Demographic, clinical and bacterial DNA findings of the 
patients with unruptured aneurysm.
Additional file 3. Measuring the depth of a gingival pocket.
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Fig. 1 The median amount of total bacterial DNA and DNA from 
Fusobacterium nucleatum in patients with unruptured intracranial 
aneurysms with and without ≤ 6 mm gingival pockets
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